Latest filing published 07 Feb 2018 for Soleno Therapeutics INC, €5,507.
Insider track record
James Walter Glasheen: trading record in brief
James Walter Glasheen has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Revance Therapeutics, Inc. and Soleno Therapeutics Inc. Between 11 February 2014 and 5 February 2018, the trades on record add up to 9 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 7 February 2018, reports a share grant of €5,507 in Soleno Therapeutics Inc. The median gap between trade and publication is zero days: most filings appear on the same day. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to James Walter Glasheen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,962 shares@ US$1.7329.2% of flowCommon StockSEC:0000899243-18-003157:0
- 13,154 shares@ US$0.5230.9% of flowCommon StockSEC:0000899243-17-023581:0
- 11,213 shares@ US$0.6131.8% of flowCommon StockSEC:0000899243-17-018364:0
- 2,578 shares@ US$0.638.1% of flowCommon StockSEC:0000899243-17-010283:0
- 52,087 sharesCommon StockSEC:0001209191-14-009043:4
- 16,703 sharesCommon StockSEC:0001209191-14-009043:0
- 149 sharesCommon StockSEC:0001209191-14-009043:1
- 622,648 sharesCommon StockSEC:0001209191-14-009043:2
- 34,427 sharesCommon StockSEC:0001209191-14-009043:3
9 of 9 declarations
